These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 12270057)

  • 1. Ki-67 expression level, histological subtype, and the International Prognostic Index as outcome predictors in mantle cell lymphoma.
    Räty R; Franssila K; Joensuu H; Teerenhovi L; Elonen E
    Eur J Haematol; 2002 Jul; 69(1):11-20. PubMed ID: 12270057
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic Value of Ki-67 Index, Cytology, and Growth Pattern in Mantle-Cell Lymphoma: Results From Randomized Trials of the European Mantle Cell Lymphoma Network.
    Hoster E; Rosenwald A; Berger F; Bernd HW; Hartmann S; Loddenkemper C; Barth TF; Brousse N; Pileri S; Rymkiewicz G; Kodet R; Stilgenbauer S; Forstpointner R; Thieblemont C; Hallek M; Coiffier B; Vehling-Kaiser U; Bouabdallah R; Kanz L; Pfreundschuh M; Schmidt C; Ribrag V; Hiddemann W; Unterhalt M; Kluin-Nelemans JC; Hermine O; Dreyling MH; Klapper W
    J Clin Oncol; 2016 Apr; 34(12):1386-94. PubMed ID: 26926679
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blastic variant of mantle cell lymphoma: a rare but highly aggressive subtype.
    Bernard M; Gressin R; Lefrère F; Drénou B; Branger B; Caulet-Maugendre S; Tass P; Brousse N; Valensi F; Milpied N; Voilat L; Sadoun A; Ghandour C; Hunault M; Leloup R; Mannone L; Hermine O; Lamy T
    Leukemia; 2001 Nov; 15(11):1785-91. PubMed ID: 11681422
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinicopathologic features and prognosis of mantle cell lymphoma: an analysis of 349 cases].
    Hou WH; Wei P; Xie JL; Zheng YY; Zhang YL; Zhou XG
    Zhonghua Bing Li Xue Za Zhi; 2018 Jun; 47(6):417-422. PubMed ID: 29886584
    [No Abstract]   [Full Text] [Related]  

  • 5. Ki-67 is a strong predictor of central nervous system relapse in patients with mantle cell lymphoma (MCL).
    Chihara D; Asano N; Ohmachi K; Nishikori M; Okamoto M; Sawa M; Sakai R; Okoshi Y; Tsukamoto N; Yakushijin Y; Nakamura S; Kinoshita T; Ogura M; Suzuki R
    Ann Oncol; 2015 May; 26(5):966-973. PubMed ID: 25712457
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The degree of overlap between the follicular dendritic cell meshwork and tumor cells in mantle cell lymphoma is associated with prognosis.
    Hou W; Wei P; Xie J; Zheng Y; Zhang Y; Zhou X
    Pathol Res Pract; 2018 Apr; 214(4):513-520. PubMed ID: 29525403
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A new prognostic index (MIPI) for patients with advanced-stage mantle cell lymphoma.
    Hoster E; Dreyling M; Klapper W; Gisselbrecht C; van Hoof A; Kluin-Nelemans HC; Pfreundschuh M; Reiser M; Metzner B; Einsele H; Peter N; Jung W; Wörmann B; Ludwig WD; Dührsen U; Eimermacher H; Wandt H; Hasford J; Hiddemann W; Unterhalt M; ;
    Blood; 2008 Jan; 111(2):558-65. PubMed ID: 17962512
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Histopathology, cell proliferation indices and clinical outcome in 304 patients with mantle cell lymphoma (MCL): a clinicopathological study from the European MCL Network.
    Tiemann M; Schrader C; Klapper W; Dreyling MH; Campo E; Norton A; Berger F; Kluin P; Ott G; Pileri S; Pedrinis E; Feller AC; Merz H; Janssen D; Hansmann ML; Krieken H; Möller P; Stein H; Unterhalt M; Hiddemann W; Parwaresch R;
    Br J Haematol; 2005 Oct; 131(1):29-38. PubMed ID: 16173960
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mantle cell lymphoma: 2013 Update on diagnosis, risk-stratification, and clinical management.
    Vose JM
    Am J Hematol; 2013 Dec; 88(12):1082-8. PubMed ID: 24273091
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Longer-term follow-up and outcome by tumour cell proliferation rate (Ki-67) in patients with relapsed/refractory mantle cell lymphoma treated with lenalidomide on MCL-001(EMERGE) pivotal trial.
    Goy A; Kalayoglu Besisik S; Drach J; Ramchandren R; Robertson MJ; Avivi I; Rowe JM; Herbrecht R; Van Hoof A; Zhang L; Cicero S; Fu T; Witzig T
    Br J Haematol; 2015 Aug; 170(4):496-503. PubMed ID: 25921098
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diffuse large B-cell lymphoma and mantle cell lymphoma of the ocular adnexal region, and lymphoma of the lacrimal gland: an investigation of clinical and histopathological features.
    Rasmussen PK
    Acta Ophthalmol; 2013 Jul; 91 Thesis 5():1-27. PubMed ID: 24041159
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Whole genome copy number analysis in search of new prognostic biomarkers in first line treatment of mantle cell lymphoma. A study by the LYSA group.
    Le Bris Y; Magrangeas F; Moreau A; Chiron D; Guérin-Charbonnel C; Theisen O; Pichon O; Canioni D; Burroni B; Maisonneuve H; Thieblemont C; Oberic L; Gyan E; Pellat-Deceunynck C; Hermine O; Delfau-Larue MH; Tessoulin B; Béné MC; Minvielle S; Le Gouill S
    Hematol Oncol; 2020 Oct; 38(4):446-455. PubMed ID: 32472610
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blastoid and common variants of mantle cell lymphoma exhibit distinct immunophenotypic and interphase FISH features.
    Parrens M; Belaud-Rotureau MA; Fitoussi O; Carerre N; Bouabdallah K; Marit G; Dubus P; de Mascarel A; Merlio JP
    Histopathology; 2006 Mar; 48(4):353-62. PubMed ID: 16487357
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mantle cell lymphoma: prognostic capacity of the Follicular Lymphoma International Prognostic Index.
    Møller MB; Pedersen NT; Christensen BE
    Br J Haematol; 2006 Apr; 133(1):43-9. PubMed ID: 16512827
    [TBL] [Abstract][Full Text] [Related]  

  • 15. No evidence of cell cycle dysregulation in mantle cell lymphoma in vivo.
    Vogt N; Abramov D; Koch K; Masqué-Soler N; Szczepanowski M; Klapper W
    Leuk Lymphoma; 2015 Jul; 56(7):2134-40. PubMed ID: 25315075
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Small cell variant of mantle cell lymphoma is an indolent lymphoma characterized by bone marrow involvement, splenomegaly, and a low Ki-67 index.
    Kimura Y; Sato K; Imamura Y; Arakawa F; Kiyasu J; Takeuchi M; Miyoshi H; Yoshida M; Niino D; Sugita Y; Morito T; Yoshino T; Nakamura S; Ohshima K
    Cancer Sci; 2011 Sep; 102(9):1734-41. PubMed ID: 21609366
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Minichromosome maintenance protein 6, a proliferation marker superior to Ki-67 and independent predictor of survival in patients with mantle cell lymphoma.
    Schrader C; Janssen D; Klapper W; Siebmann JU; Meusers P; Brittinger G; Kneba M; Tiemann M; Parwaresch R
    Br J Cancer; 2005 Oct; 93(8):939-45. PubMed ID: 16189522
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictive factors for blastoid transformation in the common variant of mantle cell lymphoma.
    Räty R; Franssila K; Jansson SE; Joensuu H; Wartiovaara-Kautto U; Elonen E
    Eur J Cancer; 2003 Feb; 39(3):321-9. PubMed ID: 12565984
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunohistochemical detection of cdc2 is useful in predicting survival in patients with mantle cell lymphoma.
    Hui D; Reiman T; Hanson J; Linford R; Wong W; Belch A; Lai R
    Mod Pathol; 2005 Sep; 18(9):1223-31. PubMed ID: 15933757
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mantle cell lymphoma shows three morphological evolutions of classical, intermediate, and aggressive forms, which occur in parallel with increased labeling index of cyclin D1 and Ki-67.
    Kimura Y; Sato K; Arakawa F; Karube K; Nomura Y; Shimizu K; Aoki R; Hashikawa K; Yoshida S; Kiyasu J; Takeuchi M; Nino D; Sugita Y; Morito T; Yoshino T; Nakamura S; Kikuchi M; Ohshima K
    Cancer Sci; 2010 Mar; 101(3):806-14. PubMed ID: 20002441
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.